- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Artgen PJSC (ABIO)
Artgen PJSC stock price live, this page displays MCX ABIO stock exchange data. View the ABIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Artgen PJSC real time stock price chart below.
What Is the Artgen PJSC Stock Price Today?
The Artgen PJSC stock price today is 76.30.
What Is the Stock Symbol for Artgen PJSC?
The stock symbol for Artgen PJSC is ""ABIO.""
What Stock Exchange Does Artgen PJSC Trade On?
Artgen PJSC is listed and trades on the Moscow stock exchange.
Is Artgen PJSC a Good Stock to Buy?
Determining whether Artgen PJSC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABIO quote. (ISIN: RU000A0JNAB6)
What Is the Artgen PJSC Stock Price Today?
The Artgen PJSC stock price today is 76.30.
What Is the Stock Symbol for Artgen PJSC?
The stock symbol for Artgen PJSC is ""ABIO.""
What Stock Exchange Does Artgen PJSC Trade On?
Artgen PJSC is listed and trades on the Moscow stock exchange.
Is Artgen PJSC a Good Stock to Buy?
Determining whether Artgen PJSC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABIO quote. (ISIN: RU000A0JNAB6)
Moscow
Currency in RUB
76.30
+0.26(+0.34%)
Real-time Data·
Fair Value
An estimate of a Artgen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.10
76.46
52 wk Range
68.04
115.00
ABIO Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
ABIO is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Artgen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.1076.46
52 wk Range
68.04115.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABIO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Artgen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Artgen PJSC Company Profile
Artgen Biotech PJSC, a biotech company, engages in the development of healthcare products in Russia. It develops Betuvax-CoV-2, a vaccine for SARS-COV-2; Tetraflubet, a Flu vaccination; Combi 5V, a Flu + COVID-19 booster vaccine; Betusphere for Immunomodulator; RBT-402, a HPV vaccine; and RBT-501, a vaccine for natural allergy. The company also offers Histograft, a Gene-activated material used as an osteoplastic material, as well as biobanking, genetic research, and regenerative medicine services. In addition, it develops various medical products, such as Xeno-Bone for bone grafting in open operations; Inject-Bone for minimally invasive bone grafting; Inject-Soft use for damage to the skin and mucous membranes; 3D-Bone use for replacement od volumetric bone defects; Cover Bone for guided bone regeneration; and Supl-Bone for bone grafting. The company was formerly known as Public Joint-Stock Company "Human Stem Cells Institute". The company was founded in 2003 and is based in Moscow, Russia.
Compare ABIO to Peers and Sector
Metrics to compare | ABIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.5x | −3.3x | −0.5x | |
PEG Ratio | 0.75 | 0.00 | 0.00 | |
Price/Book | 10.8x | 1.1x | 2.6x | |
Price / LTM Sales | 2.9x | 9.0x | 3.2x | |
Upside (Analyst Target) | - | 79.1% | 40.5% | |
Fair Value Upside | Unlock | −6.6% | 4.4% | Unlock |
Earnings
Latest Release
Apr 28, 2025
EPS / Forecast
1.18 / --
Revenue / Forecast
776.36M / --
People Also Watch
FAQ
What Stock Exchange Does Artgen Trade On?
Artgen is listed and trades on the Moscow Stock Exchange stock exchange.
What Is the Stock Symbol for Artgen?
The stock symbol for Artgen is "ABIO."
What Is the Artgen Market Cap?
As of today, Artgen market cap is 5.65B.
What Is Artgen's Earnings Per Share (TTM)?
The Artgen EPS (TTM) is 2.32.
From a Technical Analysis Perspective, Is ABIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Artgen Stock Split?
Artgen has split 0 times.
How Many Employees Does Artgen Have?
Artgen has 0 employees.
What is the current trading status of Artgen (ABIO)?
As of 25 Jul 2025, Artgen (ABIO) is trading at a price of 76.30, with a previous close of 76.04. The stock has fluctuated within a day range of 76.10 to 76.46, while its 52-week range spans from 68.04 to 115.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.